Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 52

1.

Impact of anastomotic leak on recurrence and survival after colorectal cancer surgery: a BioGrid Australia analysis.

Sammour T, Hayes IP, Jones IT, Steel MC, Faragher I, Gibbs P.

ANZ J Surg. 2016 Jun 3. doi: 10.1111/ans.13648. [Epub ahead of print]

PMID:
27255690
2.

Survival impact of the Australian National Bowel Cancer Screening Programme.

Ananda S, Wong H, Faragher I, Jones IT, Steele M, Kosmider S, Desai J, Tie J, Field K, Wong R, Tran B, Bae S, Gibbs P.

Intern Med J. 2016 Feb;46(2):166-71. doi: 10.1111/imj.12916.

PMID:
26418334
3.

Improving Quality of Life for People with Incurable Large-Bowel Obstruction: Randomized Control Trial of Colonic Stent Insertion.

Young CJ, De-Loyde KJ, Young JM, Solomon MJ, Chew EH, Byrne CM, Salkeld G, Faragher IG.

Dis Colon Rectum. 2015 Sep;58(9):838-49. doi: 10.1097/DCR.0000000000000431.

PMID:
26252845
4.

Recurrence in patients with stage I colorectal cancer.

Teloken PE, Ransom D, Faragher I, Jones I, Gibbs P, Platell C.

ANZ J Surg. 2016 Jan-Feb;86(1-2):49-53. doi: 10.1111/ans.13254. Epub 2015 Aug 2.

PMID:
26235683
5.

Colorectal preOperative Surgical Score (CrOSS) for mortality in major colorectal surgery.

Kong CH, Guest GD, Stupart DA, Faragher IG, Chan ST, Watters DA.

ANZ J Surg. 2015 Jun;85(6):403-7. doi: 10.1111/ans.13066. Epub 2015 Mar 30.

PMID:
25823601
6.

Comparing oncological outcomes of laparoscopic versus open surgery for colon cancer: Analysis of a large prospective clinical database.

Sammour T, Jones IT, Gibbs P, Chandra R, Steel MC, Shedda SM, Croxford M, Faragher I, Hayes IP, Hastie IA.

J Surg Oncol. 2015 Jun;111(7):891-8. doi: 10.1002/jso.23893. Epub 2015 Feb 24.

PMID:
25712421
7.

Comparison of ECOG/WHO performance status and ASA score as a measure of functional status.

Young J, Badgery-Parker T, Dobbins T, Jorgensen M, Gibbs P, Faragher I, Jones I, Currow D.

J Pain Symptom Manage. 2015 Feb;49(2):258-64. doi: 10.1016/j.jpainsymman.2014.06.006. Epub 2014 Jul 1.

PMID:
24996034
8.

The role of tissue diagnosis prior to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

Daniel ES, Gibbs P, Guerrieri M, Faragher I.

Colorectal Dis. 2014 Oct;16(10):783-7. doi: 10.1111/codi.12653.

PMID:
24786681
9.

Not all patients need to be discussed in a colorectal cancer MDT meeting.

Ryan J, Faragher I.

Colorectal Dis. 2014 Jul;16(7):520-6. doi: 10.1111/codi.12581.

PMID:
24617857
10.

Time to readiness for discharge is a valid and reliable measure of short-term recovery after colorectal surgery.

Fiore JF Jr, Faragher IG, Bialocerkowski A, Browning L, Denehy L.

World J Surg. 2013 Dec;37(12):2927-34. doi: 10.1007/s00268-013-2208-1.

PMID:
24101012
11.

Recalibration and validation of a preoperative risk prediction model for mortality in major colorectal surgery.

Kong CH, Guest GD, Stupart DA, Faragher IG, Chan ST, Watters DA.

Dis Colon Rectum. 2013 Jul;56(7):844-9. doi: 10.1097/DCR.0b013e31828343f2.

PMID:
23739190
12.

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer.

Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M; PRACTICAL Consortium, Ziogas A, Zheng W, Yang HP, Wu AH, Wozniak EL, Woo YL, Winterhoff B, Wik E, Whittemore AS, Wentzensen N, Weber RP, Vitonis AF, Vincent D, Vierkant RA, Vergote I, Van Den Berg D, Van Altena AM, Tworoger SS, Thompson PJ, Tessier DC, Terry KL, Teo SH, Templeman C, Stram DO, Southey MC, Sieh W, Siddiqui N, Shvetsov YB, Shu XO, Shridhar V, Wang-Gohrke S, Severi G, Schwaab I, Salvesen HB, Rzepecka IK, Runnebaum IB, Rossing MA, Rodriguez-Rodriguez L, Risch HA, Renner SP, Poole EM, Pike MC, Phelan CM, Pelttari LM, Pejovic T, Paul J, Orlow I, Omar SZ, Olson SH, Odunsi K, Nickels S, Nevanlinna H, Ness RB, Narod SA, Nakanishi T, Moysich KB, Monteiro AN, Moes-Sosnowska J, Modugno F, Menon U, McLaughlin JR, McGuire V, Matsuo K, Adenan NA, Massuger LF, Lurie G, Lundvall L, Lubiński J, Lissowska J, Levine DA, Leminen A, Lee AW, Le ND, Lambrechts S, Lambrechts D, Kupryjanczyk J, Krakstad C, Konecny GE, Kjaer SK, Kiemeney LA, Kelemen LE, Keeney GL, Karlan BY, Karevan R, Kalli KR, Kajiyama H, Ji BT, Jensen A, Jakubowska A, Iversen E, Hosono S, Høgdall CK, Høgdall E, Hoatlin M, Hillemanns P, Heitz F, Hein R, Harter P, Halle MK, Hall P, Gronwald J, Gore M, Goodman MT, Giles GG, Gentry-Maharaj A, Garcia-Closas M, Flanagan JM, Fasching PA, Ekici AB, Edwards R, Eccles D, Easton DF, Dürst M, du Bois A, Dörk T, Doherty JA, Despierre E, Dansonka-Mieszkowska A, Cybulski C, Cramer DW, Cook LS, Chen X, Charbonneau B, Chang-Claude J, Campbell I, Butzow R, Bunker CH, Brueggmann D, Brown R, Brooks-Wilson A, Brinton LA, Bogdanova N, Block MS, Benjamin E, Beesley J, Beckmann MW, Bandera EV, Baglietto L, Bacot F, Armasu SM, Antonenkova N, Anton-Culver H, Aben KK, Liang D, Wu X, Lu K, Hildebrandt MA; Australian Ovarian Cancer Study Group; Australian Cancer Study, Schildkraut JM, Sellers TA, Huntsman D, Berchuck A, Chenevix-Trench G, Gayther SA, Pharoah PD, Laird PW, Goode EL, Pearce CL.

Nat Commun. 2013;4:1628. doi: 10.1038/ncomms2629.

13.

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.

Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, Aben KK, Anton-Culver H, Antonenkova N, Antoniou AC, Armasu SM; Australian Cancer Study; Australian Ovarian Cancer Study, Bacot F, Baglietto L, Bandera EV, Barnholtz-Sloan J, Beckmann MW, Birrer MJ, Bloom G, Bogdanova N, Brinton LA, Brooks-Wilson A, Brown R, Butzow R, Cai Q, Campbell I, Chang-Claude J, Chanock S, Chenevix-Trench G, Cheng JQ, Cicek MS, Coetzee GA; Consortium of Investigators of Modifiers of BRCA1/2, Cook LS, Couch FJ, Cramer DW, Cunningham JM, Dansonka-Mieszkowska A, Despierre E, Doherty JA, Dörk T, du Bois A, Dürst M, Easton DF, Eccles D, Edwards R, Ekici AB, Fasching PA, Fenstermacher DA, Flanagan JM, Garcia-Closas M, Gentry-Maharaj A, Giles GG, Glasspool RM, Gonzalez-Bosquet J, Goodman MT, Gore M, Górski B, Gronwald J, Hall P, Halle MK, Harter P, Heitz F, Hillemanns P, Hoatlin M, Høgdall CK, Høgdall E, Hosono S, Jakubowska A, Jensen A, Jim H, Kalli KR, Karlan BY, Kaye SB, Kelemen LE, Kiemeney LA, Kikkawa F, Konecny GE, Krakstad C, Kjaer SK, Kupryjanczyk J, Lambrechts D, Lambrechts S, Lancaster JM, Le ND, Leminen A, Levine DA, Liang D, Lim BK, Lin J, Lissowska J, Lu KH, Lubiński J, Lurie G, Massuger LF, Matsuo K, McGuire V, McLaughlin JR, Menon U, Modugno F, Moysich KB, Nakanishi T, Narod SA, Nedergaard L, Ness RB, Nevanlinna H, Nickels S, Noushmehr H, Odunsi K, Olson SH, Orlow I, Paul J, Pearce CL, Pejovic T, Pelttari LM, Pike MC, Poole EM, Raska P, Renner SP, Risch HA, Rodriguez-Rodriguez L, Rossing MA, Rudolph A, Runnebaum IB, Rzepecka IK, Salvesen HB, Schwaab I, Severi G, Shridhar V, Shu XO, Shvetsov YB, Sieh W, Song H, Southey MC, Spiewankiewicz B, Stram D, Sutphen R, Teo SH, Terry KL, Tessier DC, Thompson PJ, Tworoger SS, van Altena AM, Vergote I, Vierkant RA, Vincent D, Vitonis AF, Wang-Gohrke S, Palmieri Weber R, Wentzensen N, Whittemore AS, Wik E, Wilkens LR, Winterhoff B, Woo YL, Wu AH, Xiang YB, Yang HP, Zheng W, Ziogas A, Zulkifli F, Phelan CM, Iversen E, Schildkraut JM, Berchuck A, Fridley BL, Goode EL, Pharoah PD, Monteiro AN, Sellers TA, Gayther SA.

Nat Commun. 2013;4:1627. doi: 10.1038/ncomms2613.

14.

Dietary antioxidants and risk of Barrett's esophagus and adenocarcinoma of the esophagus in an Australian population.

Ibiebele TI, Hughes MC, Nagle CM, Bain CJ, Whiteman DC, Webb PM; Study of Digestive Health and Australian Cancer Study.

Int J Cancer. 2013 Jul;133(1):214-24. doi: 10.1002/ijc.28016. Epub 2013 Feb 12.

15.

Long-term outcomes of the australasian randomized clinical trial comparing laparoscopic and conventional open surgical treatments for colon cancer: the Australasian Laparoscopic Colon Cancer Study trial.

Bagshaw PF, Allardyce RA, Frampton CM, Frizelle FA, Hewett PJ, McMurrick PJ, Rieger NA, Smith JS, Solomon MJ, Stevenson AR; Australasian Laparoscopic Colon Cancer Study Group.

Ann Surg. 2012 Dec;256(6):915-9. doi: 10.1097/SLA.0b013e3182765ff8.

PMID:
23154392
16.

Criteria to determine readiness for hospital discharge following colorectal surgery: an international consensus using the Delphi technique.

Fiore JF Jr, Bialocerkowski A, Browning L, Faragher IG, Denehy L.

Dis Colon Rectum. 2012 Apr;55(4):416-23. doi: 10.1097/DCR.0b013e318244a8f2.

PMID:
22426265
17.

Surgical oncology issues in locally advanced rectal cancer.

Ooi K, Gibbs P, Faragher I.

ANZ J Surg. 2011 Nov;81(11):790-6. Review.

PMID:
22295389
18.

The influence of prediagnostic demographic and lifestyle factors on esophageal squamous cell carcinoma survival.

Thrift AP, Nagle CM, Fahey PP, Russell A, Smithers BM, Watson DI, Whiteman DC; Australian Cancer Study Clinical Follow-Up Study.

Int J Cancer. 2012 Sep 1;131(5):E759-68. doi: 10.1002/ijc.27420. Epub 2012 Feb 28.

19.

Prevalence and determinants of frequent gastroesophageal reflux symptoms in the Australian community.

Pandeya N, Green AC, Whiteman DC; Australian Cancer Study.

Dis Esophagus. 2012 Sep-Oct;25(7):573-83. doi: 10.1111/j.1442-2050.2011.01287.x. Epub 2011 Nov 30.

PMID:
22128757
20.

Dietary patterns and risk of oesophageal cancers: a population-based case-control study.

Ibiebele TI, Hughes MC, Whiteman DC, Webb PM; Australian Cancer Study.

Br J Nutr. 2012 Apr;107(8):1207-16. doi: 10.1017/S0007114511004247. Epub 2011 Sep 7.

PMID:
21899799
Items per page

Supplemental Content

Loading ...
Write to the Help Desk